Literature DB >> 16510531

Acute alcohol use among patients with acute hip fractures: a descriptive incidence study in southeastern Finland.

J-P Kaukonen1, I Nurmi-Lüthje, P Lüthje, H Naboulsi, S Tanninen, M Kataja, M-L Kallio, M Leppilampi.   

Abstract

AIM: To assess the very recent use of alcohol among patients admitted to two Finnish hospitals due to an acute hip fracture.
METHOD: Very recent use of alcohol was recorded according to the patient's or the relatives' report. Ethanol was measured in blood samples taken at admission. Serum gamma-glutamyltransferase, aspartate aminotransferase and alanine aminotransferase, and vitamin D concentration were measured. Reported use of medication, vitamin D, and/or calcium supplementation was recorded.
RESULTS: Complete data were obtained on 222 of 375 eligible patients; 71% of those enrolled were women. The mean age of women was 80.5 years (SD 10) and of men 73 years (SD 12) (P < 0.001). The fracture type was femoral neck in 50%, trochanteric in 41%, and subtrochanteric in 9%. The use of alcohol within 24 h before the accident leading to hip fracture was reported by 21.5% of men and 7% of women; positive serum alcohol levels were noted in 17% (19% of men and 16% of women) and 2.2% had a level of >1.0 mg/l. Recent alcohol use was more common among patients in the age group of 65-74 years than among older patients (P < 0.001). The use of alcohol was associated strongly with tobacco use (P = 0.00012) but had no association with vitamin D levels. Alcohol users used less medication than non-users (P < 0.01). Women seemed to conceal their use of alcohol more than men (P < 0.005).
CONCLUSIONS: Alcohol consumption was common among patients with an acute hip fracture, being more common in younger than in older patients. Use of alcohol in the 24 h prior to the injury was reported by 21.5% of men and 7% of women. Alcohol concentration in blood was positive in 19% of men and 16% of women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510531     DOI: 10.1093/alcalc/agh259

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  6 in total

1.  Psychotropics and weak opioid analgesics in plasma samples of older hip fracture patients - detection frequencies and consistency with drug records.

Authors:  Ragnhild Birkeland Waade; Espen Molden; Mette Irene Martinsen; Monica Hermann; Anette Hylen Ranhoff
Journal:  Br J Clin Pharmacol       Date:  2017-03-09       Impact factor: 4.335

2.  Antioxidant therapy attenuates deficient bone fracture repair associated with binge alcohol exposure.

Authors:  Dustin L Volkmer; Benjamin Sears; Kristen L Lauing; Rachel K Nauer; Philip M Roper; Sherri Yong; Michael Stover; John J Callaci
Journal:  J Orthop Trauma       Date:  2011-08       Impact factor: 2.512

3.  Prevalence of at-risk drinking among older adults and associated sociodemographic and health-related factors.

Authors:  S Immonen; J Valvanne; K H Pitkala
Journal:  J Nutr Health Aging       Date:  2011-11       Impact factor: 4.075

4.  Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.

Authors:  Ilona Nurmi-Lüthje; Peter Lüthje; Juha-Pekka Kaukonen; Matti Kataja; Salla Kuurne; Helena Naboulsi; Kalevi Karjalainen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption.

Authors:  Naoko Hidaka; Hajime Kato; Minae Koga; Masaki Katsura; Yuko Oyama; Yuka Kinoshita; Seiji Fukumoto; Noriko Makita; Masaomi Nangaku; Nobuaki Ito
Journal:  Bone Rep       Date:  2021-10-16

6.  Chronic Alcohol Dysregulates Skeletal Muscle Myogenic Gene Expression after Hind Limb Immobilization in Female Rats.

Authors:  Danielle E Levitt; Alice Y Yeh; Matthew J Prendergast; Ronald G Budnar Jr; Katherine A Adler; Garth Cook; Patricia E Molina; Liz Simon
Journal:  Biomolecules       Date:  2020-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.